Ovine IFN alpha Recombinant Protein

Catalog Number:
RP1027V
Availability:
In stock
Application:
Cell Culture, ELISA Standard, ELISpot Control, Western Blot Control
100% Homology:
Ovis aries (sheep)
  • Ovine IFN-α (catalog RP1027V) is a yeast-derived cytokine supplied lyophilized without carrier protein in 10% trehalose; it has no affinity tags and is naturally endotoxin-free, and should be reconstituted in sterile PBS that contains at least 0.1% carrier protein. The protein is ~19.0 kDa, 166 amino acids long (full sequence provided; variant [Ala75Thr], [Ser164Arg]), and >98% pure by SDS-PAGE, with 100% amino-acid homology to sheep. Store at -20°C (stable up to twelve months from date of receipt; working aliquots with carrier protein stable ~3 months) and avoid repeated freeze/thaw cycles. Product origin is the USA. It is commonly used to study type I interferon signaling and antiviral immune responses (including regulation of innate immunity and gene expression); typical experimental uses include cell-culture stimulation and antiviral assays, signaling and gene-expression studies, ELISA and neutralization assays, flow-cytometry and Western blot controls, and antibody generation/validation. Kingfisher Biotech products are supplied for research applications and are not intended for medicinal, diagnostic, or therapeutic use.
Amino Acid SequenceCHLPHTHSLA NRRVLTLLRQ LRRVSPSSCL QDRKDFAFAQ EVLGGSQLRK VQAISVLHEV TQHTFQLFST EGSATAWDQS LLDKLRAALD QQLTDLQACL RQEEGLRGAP LLKEDSSLAV RKYFHRVTLY LQEKGHSPCA WEVVRAEVMR AFSSSTNLQE RFRRKD (166)
EndotoxinNaturally endotoxin-free
Storage Conditions-20°C
Molecular Weight19.0 kDa
Purity>98% as visualized by SDS-PAGE analysis.
Country Of OriginUSA
  • Ovine Interferon-Alpha (IFN-α) is a type I interferon produced primarily by plasmacytoid dendritic cells and virus-infected cells in sheep (Ovis aries), where it plays a central role in early innate antiviral immunity. Upon binding to the type I interferon receptor complex (IFNAR1/IFNAR2), ovine IFN-α activates JAK/STAT signaling pathways, leading to induction of interferon-stimulated genes (ISGs) that inhibit viral replication, enhance antigen presentation, and promote activation of natural killer (NK) cells and adaptive immune responses. Ovine IFN-α is critically involved in host defense against economically significant viral infections such as bluetongue virus (BTV), ovine progressive pneumonia virus (maedi-visna; a small ruminant lentivirus), peste des petits ruminants virus (PPRV), and sheep pox virus. Viral modulation or evasion of type I interferon responses can contribute to persistence, chronic inflammation, or systemic disease. The magnitude and timing of IFN-α induction influence disease outcome, viral shedding, and vaccine responsiveness in sheep populations. In veterinary and comparative research, characterization of ovine IFN-α supports studies of lentiviral pathogenesis, arboviral disease, mucosal antiviral immunity, and type I interferon biology in ruminants, contributing to improved disease control strategies and broader understanding of antiviral immune mechanisms relevant to both animal and human health.

Please choose a size to see price


Reagents for Animal Model and Animal Health Research

Kingfisher Biotech, Inc.
1000 Westgate Drive
Suite 123
Saint Paul, MN 55114

Phone: 651-646-0089
Fax: 651-646-0095

Animal Antibodies

Newsletter

"